Skip to Main Content

Advertisement

Skip Nav Destination

CpG oligodeoxynucleotide 1826 enhances radiotherapeutic response of both immunogenic and non-immunogenic tumors

Cancer Res (2005) 65 (9_Supplement): 168.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal